en
Scientific article
English

Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases

Published inActa oncologica, vol. 52, no. 8, p. 1622-1628
Publication date2013
Abstract

Substantial survival may be observed with oligometastatic prostate cancer. Combining androgen deprivation (AD) and high-dose external beam radiotherapy (RT) to isolated regional or distant lesions may be proposed for these patients and the outcome of this strategy is the purpose of the present report.

Keywords
  • Aged
  • Aged, 80 and over
  • Androgen Antagonists/therapeutic use
  • Chemoradiotherapy
  • Dose-Response Relationship, Radiation
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Neoadjuvant Therapy
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local/mortality/pathology/therapy
  • Neoplasm Staging
  • Positron-Emission Tomography
  • Prognosis
  • Prostatic Neoplasms/mortality/pathology/therapy
  • Radiopharmaceuticals/diagnostic use
  • Radiotherapy, Conformal
  • Survival Rate
  • Tomography, X-Ray Computed
Citation (ISO format)
SCHICK, Ulricke et al. Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases. In: Acta oncologica, 2013, vol. 52, n° 8, p. 1622–1628. doi: 10.3109/0284186X.2013.764010
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0284-186X
542views
0downloads

Technical informations

Creation12/22/2014 3:34:00 PM
First validation12/22/2014 3:34:00 PM
Update time03/14/2023 10:33:33 PM
Status update03/14/2023 10:33:33 PM
Last indexation01/16/2024 3:31:22 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack